Max Healthcare Institute Limited — PPTs, 20-02-2026: Investor Presentation

Max Healthcare shows solid performance with strong 9M FY26 financials: Net Revenue up 19% YoY to ₹ 7,524 Cr, Operating EBITDA grew 16% to ₹ 1,956 Cr, and Profit after tax jumped 30% to ₹ 1,244 Cr. Q3 also saw good growth, with Net Revenue at ₹ 2,484 Cr (+9% YoY) and Profit after tax at ₹ 344 Cr (+9% YoY). The company maintains ~76% occupancy and a 26% ROCE.

Growth is fueled by strategic capacity expansion, targeting 8,900+ new beds, including ~4,600 in the next 3-4 years through brownfield projects like Mohali Tower 2 (+80% capacity) and Nanavati-Max Tower 2 (+85%). Max Smart expansion is also set to boost Saket Complex capacity by over 50%. Max Healthcare is leveraging its dominant metro presence and medical tourism opportunities.

The company is also pushing capital-light adjacencies with Max Lab (9M FY26 net revenue ₹ 144 Cr) and Max@Home (9M FY26 gross revenue ₹ 190 Cr). Digital initiatives are strong, with the 'Max MyHealth' platform seeing 1.18 lakh+ monthly active users. Management is focused on delivering high returns and long-term growth, supported by robust cash flows and low debt.